[Rapport de recherche]Le marché du génome numérique était évalué à 11 065,31 millions de dollars américains en 2019 et devrait atteindre 20 812,81 millions de dollars américains en 2027 ; il devrait croître à un TCAC de 8,4 % de 2020 à 2027.
Le génome numérique est un ensemble numérique complet de matériel génétique présent dans un organisme ou une cellule. La technologie du génome numérique traite des gènes et de leurs fonctions pour trouver les causes des maladies chroniques et aussi pour les réparer. La technologie est associée aux progrès qui contribuent à rendre les soins de santé plus personnels et plus efficaces pour le traitement. De plus, le génome numérique est un moyen plus simple de recueillir des informations sur la maladie chronique. La technologie est utilisée par les professionnels pour examiner de plus près les maladies génétiques composées, telles que le cancer. Le génome numérique agit comme un support qui permet un accès instantané aux combinaisons de traits pour résoudre des requêtes personnalisées apparemment sans fin.
Régions lucratives pour le marché du génome numérique
< h3>Aperçu du marché
Financement croissant pour la génomique
La technologie de séquençage génomique est en train de passer rapidement à la pratique clinique, et sa mise en uvre dans les systèmes de santé a été soutenue par un investissement gouvernemental substantiel, représentant ~4 milliards de dollars US dans au moins 14 pays. Ces initiatives nationales de médecine génomique entraînent des changements transformateurs dans des conditions réelles tout en s'attaquant simultanément aux obstacles à la mise en uvre et à la collecte de preuves pour une adoption plus large, stimulant ainsi la croissance du marché. De plus, le Royaume-Uni a annoncé le plus grand projet de génome au monde dans le cadre d'une collaboration public-privé de 200 millions entre des organisations caritatives et pharmaceutiques. Le Royaume-Uni a déjà développé la plus grande base de données génomiques au monde grâce au projet 100 000 génomes. Dirigé par Innovate UK dans le cadre de UK Research and Innovation, le projet financera les chercheurs et l'industrie pour combiner les données et les preuves du monde réel des services de santé britanniques et créer de nouveaux produits et services qui diagnostiquent efficacement les maladies. De plus, en novembre 2018, Stilla Technologies a annoncé avoir réalisé un tour de financement de série A de 18,3 millions de dollars américains (16 millions d'euros) mené par Illumina Ventures. La société utilisera les fonds pour commercialiser son système de PCR numérique Naica et développer des applications cliniques.
Grâce au financement continu des fabricants et du gouvernement dans le domaine de la génomique, le marché du génome numérique devrait connaître une croissance au cours de la période de prévision.
Insights basés sur le produit
Sur la base du produit, le marché du génome numérique est segmenté en analyse d'ADN/ARN, puces de séquençage, séquençage et analyseur instruments, instruments de préparation d'échantillons, logiciels de séquençage et d'analyse. Le segment des instruments de séquençage et d'analyse détenait la plus grande part du marché en 2019, en raison d'avantages tels que l'adoption croissante du séquençage des instruments d'analyse par les sociétés pharmaceutiques et biopharmaceutiques des économies avancées. De plus, les entreprises se concentrent sur la fourniture d'instruments de qualité supérieure aux centres de recherche et aux sociétés pharmaceutiques impliquées dans le développement de thérapies pour les maladies génétiques. Par exemple, Thermo Fisher Scientific a annoncé le lancement de son système Ion Torrent Genexus, la première plate-forme de séquençage de nouvelle génération (NGS) entièrement intégrée dotée d'un flux de travail automatisé de l'échantillon au rapport qui fournit des résultats économiques en une seule journée.
Marché mondial du génome numérique, par produit - 2019 & 2027
Insights basés sur les applications
Sur la base des applications, le marché du génome numérique est segmenté en diagnostic, agriculture, recherche universitaire, découverte de médicaments, médecine personnalisée et autres applications. En 2019, le segment des diagnostics détenait la plus grande part du marché mondial du génome numérique en raison de facteurs tels que le lancement de produits de diagnostic innovants, l'augmentation des investissements dans les technologies du génome et l'expansion des capacités du génome numérique dans les applications de diagnostic. Par exemple, en avril 2020, Personal Genome Diagnostics, la société engagée dans le développement d'un nouveau kit de diagnostic pour le profilage génomique de différents cancers, a reçu l'approbation de la FDA pour son test complet de tissu PGDx elio.
Utilisateur final - Informations basées sur l'utilisateur
En fonction de l'utilisateur final, le marché du génome numérique est segmenté en laboratoires de diagnostic et médico-légaux, instituts de recherche universitaires, hôpitaux et autres utilisateurs finaux. Le segment des diagnostics et des laboratoires médico-légaux détenait la plus grande part du marché en 2019, en raison de l'importance croissante accordée à l'adoption des génomes numériques dans les diagnostics et les laboratoires médico-légaux. De plus, les récents progrès technologiques aideront à résoudre plus de cas en moins de temps et produiront des pistes d'enquête pour des cas qui auraient atteint des impasses et offriront des opportunités lucratives au cours de la période de prévision. Par exemple, la technologie Illumina SBS, le système MiSeq FGx est le premier système NGS conçu spécifiquement pour les applications génomiques médico-légales.
Insights stratégiques
Les lancements de produits et la stratégie d'expansion sont couramment adoptés par les entreprises pour étendre leur présence dans le monde entier et répondre à la demande croissante. Cette stratégie est le plus souvent adoptée par les acteurs du marché afin d'élargir leur portefeuille de produits.
Les acteurs du marché opérant sur le marché du génome numérique ont adopté la stratégie d'innovation produit pour répondre à l'évolution de la demande des clients à travers le monde, ce qui permet également aux acteurs de conserver leur marque à l'échelle mondiale.
Marché du génome numérique - Par produit
- Instruments de séquençage et d'analyse
- Analyse d'ADN/ARN
- Puces de séquençage
- Instruments de préparation d'échantillons,
- Logiciel de séquençage et d'analyse
Marché du génome numérique - Par application
- Diagnostic
- Agricole
- Recherche universitaire
- Découverte de médicaments
- Médecine personnalisée
- Autre application
Marché du génome numérique Par utilisateur final
- Laboratoires de diagnostic et de criminalistique
- Instituts de recherche universitaires
< li>Hôpitaux
- Autre utilisateur final
Marché du génome numérique Par zone géographique
- Amérique du Nord
- États-Unis< /li>
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Moyen-Orient et amp ; Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste de la MEA
- Amérique du Sud (SAM)
- Brésil
- Argentine
- Reste de SAM
Profils d'entreprises
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- QIAGEN
- GenomeMe
- NanoString Technologies, Inc.
- BD
- bioMérieux SA
- GenMark Diagnostics, Inc.
- Perkin Elmer, Inc.
< li>Hôpitaux
- États-Unis< /li>
- Canada
- Mexique
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste de la MEA
- Brésil
- Argentine
- Reste de SAM
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Digital genome is a technology which deals with the genes and their functions to help to find the causes behind the chronic diseases and also to fix them. Digital genome is a complete digital set of genetic material that present in an organism or a cell. The technology is associated with the advancements that helps to make healthcare more personal and more effective for the treatment. Moreover, the digital genome is an easier way to gathering the information about the chronic disease. The technology is used by the professionals to get a closer look of genetic composed diseases, such as cancer. A digital genome act as a supporter that enables instant access to trait combinations to solve apparently endless custom queries.
The factors that are driving growth of the market are increasing prevalence of increasing prevalence of chronic diseases, and growing funding for genomics. Moreover, increasing technological advancement in digital genome field are offering lucrative opportunities for the growth of the market.
The digital genome market majorly consists of the players such as THERMO FISHER SCIENTIFIC INC., F. HOFFMANN-LA ROCHE LTD, Illumina, Inc., QIAGEN, GenomeMe, NanoString Technologies, Inc., BD, bioMerieux SA, GenMark Diagnostics, Inc., and Perkin Elmer, Inc. among others.
The List of Companies - Digital Genome Market
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- QIAGEN
- GenomeMe
- NanoString Technologies, Inc.
- BD
- bioMerieux SA
- GenMark Diagnostics, Inc.
- Perkin Elmer, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
May 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
May 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
May 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)